Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Materials Science & Engineering. C, Materials for Biological Applications|March 21, 2019
Surface charge of well-defined polymeric nano-stars regulates non-invasive fluorescence imaging of lymph nodeJiejing Li, Zhangyuan Gu, Mingquan Liao, et al.
International Journal of Clinical and Experimental Pathology|June 23, 2015
Predictors for contralateral prophylactic mastectomy in breast cancer patientsYun Fu, Zhigang Zhuang, Michelle Dewing, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|September 1, 2016
[Knowledge and willingness of breast cancer patients from Shanghai for genetic counseling and gene testing]Xiaolin Cheng, Zhengdong Li, Xiaoyin Sun, et al.
Wei Sheng Wu Xue Bao = Acta Microbiologica Sinica|April 26, 2013
[Isolation and characterization of the salt-tolerant aerobic denitrifying bacterial strain A-13]Yonghe Han, Wenxian Zhang, Zhigang Zhuang, et al.
BMC Pregnancy and Childbirth|October 22, 2015
Evaluation of the impact of breast milk expression in early postpartum period on breastfeeding duration: a prospective cohort studyBeiqi Jiang, Jing Hua, Yijing Wang, et al.
Environmental Technology|September 2, 2014
Co-immobilization of Pseudomonas stutzeri YHA-13 and Alcaligenes sp. ZGED-12 with polyvinyl alcohol-alginate for removal of nitrogen and phosphorus from synthetic wastewaterYonghe Han, Wenxian Zhang, Wenxian Lu, et al.
SLAS Technology|September 19, 2024
Connexin 43 controls metastatic behavior in triple negative breast cancer through TGFβ1-Smad3-intergin αV signaling axis Based on optical image diagnosisYun Fu, Xiaoyin Sun, Qizhi He, et al.
BMC Cancer|June 15, 2019
MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147Cheng Wang, Cheng Xu, Ruijie Niu, et al.
Nanomedicine (London, England)|April 14, 2015
Advances and perspectives in nanoprobes for noninvasive lymph node mappingJiejing Li, Zhigang Zhuang, Zhigang Zhuan, et al.
Chinese Clinical Oncology|June 11, 2024
TPD52 is a prognostic biomarker and potential therapeutic target for ER+/PR+/HER2+ breast cancerXiaolin Cheng, Zhengdong Li, Xiaoqing Jia, et al.
Pageof 4